Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

29
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

42
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42
Dementia l: Introduction01:22

Dementia l: Introduction

35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

A Brain Connectivity Approach to Detect Diffusion-Weighted Imaging Changes in Post-Traumatic Epilepsy.

Bioengineering (Basel, Switzerland)·2026
Same author

Enhancing breath-based diagnostics through eXplainable Artificial Intelligence.

PloS one·2026
Same author

Higher-order synergy-based ranking in transcriptomic communities via latent factors and O-information.

Physics in medicine and biology·2026
Same author

Explainable Bidirectional Long Short-Term Memory Networks Learn Chemistry from SMILES for Predicting Toxicity of Androgen and Estrogen Receptor Chemicals.

ACS omega·2026
Same author

Leveraging AI and multi-source satellite imagery for multi-hazard monitoring and susceptibility mapping in urban areas.

Scientific reports·2026
Same author

Explainable AI-Based Hyperspectral Classification Reveals Differences in Spectral Response over Phenological Stages.

Biology·2026
Same journal

Erratum: Low-dimensional model for adaptive networks of spiking neurons [Phys. Rev. E 111, 014422 (2025)].

Physical review. E·2026
Same journal

Disentangling the effects of many-body forces on depletion interactions.

Physical review. E·2026
Same journal

Charge transport and mode transition in dual-energy electron beam diodes.

Physical review. E·2026
Same journal

Optimization of multisite reactions in complex compartmentalized media.

Physical review. E·2026
Same journal

Origin of geometric cohesion in nonconvex granular materials: Interplay between interdigitation and rotational constraints enhancing frictional stability.

Physical review. E·2026
Same journal

Interaction of walkers with a standing Faraday wave.

Physical review. E·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: May 5, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.2K

Inteligencia Artificial Explicable basada en gráficos aleatorios exponenciales para la enfermedad de Alzheimer.

Nicola Amoroso1,2, Ester Pantaleo2,3, Marianna La Rocca2,3

  • 1Università degli Studi di Bari Aldo Moro, Dipartimento di Farmacia - Scienze del Farmaco, Bari, Italy.

Physical review. E
|February 20, 2026
PubMed
Resumen
Este resumen es generado por máquina.

Los modelos de gráficos aleatorios exponenciales (ERG) caracterizan eficazmente los impactos de la enfermedad de Alzheimer (EA) en la conectividad cerebral. Este enfoque de física estadística identifica con precisión los patrones de enfermedad y las regiones cerebrales afectadas, ayudando al diagnóstico y la comprensión de los mecanismos de la enfermedad.

Más Videos Relacionados

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.5K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

598

Videos de Experimentos Relacionados

Last Updated: May 5, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.2K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.5K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

598

Área de la Ciencia:

  • Física estadística de las estadísticas.
  • Ciencia de la red Ciencia de la red.
  • La neuroimagen es una técnica de neuroimagen.

Sus antecedentes:

  • La enfermedad de Alzheimer (EA) tiene un impacto significativo en la conectividad cerebral.
  • Comprender estos cambios es crucial para el diagnóstico y el tratamiento.
  • Es posible que los métodos existentes no capturen completamente las alteraciones complejas de la red.

Objetivo del estudio:

  • Aplicar modelos de gráficos aleatorios exponenciales (ERG) para caracterizar los cambios en la conectividad cerebral en la enfermedad de Alzheimer (EA).
  • Evaluar la eficacia de los modelos ERG en la identificación de patrones de enfermedad globales y locales.
  • Explorar el potencial de los modelos ERG para sistemas de apoyo al diagnóstico.

Principales métodos:

  • Se utilizaron imágenes de resonancia magnética (IRM) ponderadas T1 de 126 controles normales (NC) y 92 pacientes con AD.
  • Redes de conectividad cerebral construidas donde los nodos representan regiones cerebrales y los enlaces representan relaciones estructurales.
  • Aplicó modelos de gráficos aleatorios exponenciales (ERG) para analizar los datos de la red.

Principales resultados:

  • Los modelos ERG describieron con éxito los patrones de conectividad cerebral global y local asociados con la enfermedad de Alzheimer.
  • Logró una alta precisión de clasificación de 0.82±0.08 para distinguir a los pacientes con EA de los controles.
  • Se identificaron regiones específicas del cerebro más afectadas por la enfermedad.

Conclusiones:

  • Los modelos de gráficos aleatorios exponenciales (ERG) son una herramienta poderosa para analizar las alteraciones de la conectividad cerebral en la enfermedad de Alzheimer (EA).
  • El enfoque demuestra el potencial para el desarrollo de sistemas innovadores de apoyo al diagnóstico y la comprensión de la patología de la enfermedad.
  • La generalidad de la metodología sugiere una amplia aplicabilidad a otras enfermedades y tipos de datos.